Compare Archer-Daniels-Midland Co (ADM) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Archer-Daniels-Midland Co vs Novartis AG — how do they compare? Archer-Daniels-Midland Co trades at $80.23 (market cap $38.78B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 7.6× Archer-Daniels-Midland Co's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| ADM | NVS | |
|---|---|---|
Market Cap | $38.78B | $295.37B |
Sector | Consumer Staples | Health |
52-Week High | $87.32 | $168.62 |
52-Week Low | $56.00 | $119.31 |
Enterprise Value | $47.03B | $336.69B |
Dividend Yield | 2.59% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Archer-Daniels-Midland Co
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
